Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jürgen Prattes

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Balkan Medical Journal|June 8, 2022
Bilateral Necrotizing Polymicrobial ThrombophlebitisPhilipp Jud, Jürgen Prattes
Antimicrobial Agents and Chemotherapy|June 22, 2016
Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State LevelsJürgen Prattes, Wiebke Duettmann, Martin Hoenigl
Medicine|July 25, 2020
Simulation-based training and assessment of mobile pre-hospital SARS-CoV-2 diagnostic teams in Styria, AustriaLukas P Mileder, Gerhilde Schüttengruber, Jürgen Prattes, et al.
Wiener Klinische Wochenschrift|February 18, 2021
Sampling site matters when testing for COVID-19 after total laryngectomy: a case reportJohannes Schmid, Jürgen Prattes, Ann-Katrin Kaufmann-Bühler, et al.
GMS Infectious Diseases|January 24, 2019
suPAR remains uninfluenced by surgery in septic patients with bloodstream infectionJasmin Rabensteiner, Florian Prüller, Jürgen Prattes, et al.
Frontiers in Microbiology|January 26, 2017
Mycobiome in the Lower Respiratory Tract - A Clinical PerspectiveRobert Krause, Christine Moissl-Eichinger, Bettina Halwachs, et al.
Mycoses|July 22, 2014
Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgeryJürgen Prattes, Martin Hoenigl, Jasmin Rabensteiner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2024
Which trial do we need? Shorter antifungal treatment for candidemia - challenging the 14-day dogmaNico Bekaan, Oliver A Cornely, Tim Friede, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2018
Antifungal Prophylaxis with Posaconazole Delayed-Release Tablet and Oral Suspension in a Real-Life Setting: Plasma Levels, Efficacy, and TolerabilityDavid Lenczuk, Wilma Zinke-Cerwenka, Hildegard Greinix, et al.
International Journal of Antimicrobial Agents|July 26, 2014
Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignanciesMartin Hoenigl, Wiebke Duettmann, Reinhard B Raggam, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Balkan Medical Journal|June 8, 2022
Bilateral Necrotizing Polymicrobial ThrombophlebitisPhilipp Jud, Jürgen Prattes
Antimicrobial Agents and Chemotherapy|June 22, 2016
Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State LevelsJürgen Prattes, Wiebke Duettmann, Martin Hoenigl
Medicine|July 25, 2020
Simulation-based training and assessment of mobile pre-hospital SARS-CoV-2 diagnostic teams in Styria, AustriaLukas P Mileder, Gerhilde Schüttengruber, Jürgen Prattes, et al.
Wiener Klinische Wochenschrift|February 18, 2021
Sampling site matters when testing for COVID-19 after total laryngectomy: a case reportJohannes Schmid, Jürgen Prattes, Ann-Katrin Kaufmann-Bühler, et al.
GMS Infectious Diseases|January 24, 2019
suPAR remains uninfluenced by surgery in septic patients with bloodstream infectionJasmin Rabensteiner, Florian Prüller, Jürgen Prattes, et al.
Frontiers in Microbiology|January 26, 2017
Mycobiome in the Lower Respiratory Tract - A Clinical PerspectiveRobert Krause, Christine Moissl-Eichinger, Bettina Halwachs, et al.
Mycoses|July 22, 2014
Serum 1,3-beta-d-glucan for antifungal treatment stratification at the intensive care unit and the influence of surgeryJürgen Prattes, Martin Hoenigl, Jasmin Rabensteiner, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 9, 2024
Which trial do we need? Shorter antifungal treatment for candidemia - challenging the 14-day dogmaNico Bekaan, Oliver A Cornely, Tim Friede, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2018
Antifungal Prophylaxis with Posaconazole Delayed-Release Tablet and Oral Suspension in a Real-Life Setting: Plasma Levels, Efficacy, and TolerabilityDavid Lenczuk, Wilma Zinke-Cerwenka, Hildegard Greinix, et al.
International Journal of Antimicrobial Agents|July 26, 2014
Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignanciesMartin Hoenigl, Wiebke Duettmann, Reinhard B Raggam, et al.
Pageof 2